drugset / Trial / NCT01347671
Safety and Efficacy of GRT6005 in Pain Due to Diabetic Polyneuropathy
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this trial is to investigate the efficacy and safety of GRT6005 in patients with painful diabetic neuropathy.
Timeline
- Start
- 2011-05
- Primary completion
- 2012-01
- Completion
- 2012-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Cebranopadol | Small molecule | 25 ug | — |
| Comparator | Cebranopadol | Small molecule | 75 ug | — |
| Comparator | Cebranopadol | Small molecule | 200 ug | — |